Seeyond’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.22M Buy
13,211
+1,756
+15% +$305K 0.21% 159
2022
Q3
$2.03M Buy
11,455
+1,902
+20% +$376K 0.24% 113
2022
Q2
$1.96M Buy
9,553
+408
+4% +$86.5K 0.22% 135
2022
Q1
$2.17M Sell
9,145
-1,206
-12% -$283K 0.22% 138
2021
Q4
$2.36M Sell
10,351
-41
-0.4% -$9.02K 0.22% 132
2021
Q3
$2.01M Buy
10,392
+1,166
+13% +$236K 0.19% 160
2021
Q2
$1.96M Sell
9,226
-49
-0.5% -$10.3K 0.18% 182
2021
Q1
$1.89M Buy
9,275
+1,449
+19% +$285K 0.19% 172
2020
Q4
$1.42M Sell
7,826
-20,421
-72% -$3.47M 0.15% 236
2020
Q3
$4.73M Buy
28,247
+1,903
+7% +$321K 0.51% 31
2020
Q2
$4.28M Sell
26,344
-25,705
-49% -$4.61M 0.49% 31
2020
Q1
$3.31M Sell
52,049
-1,800
-3% -$358K 0.46% 37
2019
Q4
$10.8M Buy
53,849
+493
+0.9% +$101K 1.13% 3
2019
Q3
$11.3M Sell
53,356
-11,059
-17% -$2.31M 1.17% 3
2019
Q2
$12.5M Sell
64,415
-18,575
-22% -$3.42M 1.3% 2
2019
Q1
$13.7M Buy
82,990
+23,448
+39% +$4.15M 1.3% 3
2018
Q4
$11.2M Buy
+59,542
New +$11M 1.55% 2

Other funds holding CME

Seeyond's CME Position: Q4 2022 in Review

Seeyond increased its CME Group (CME) stake by 15% in Q4 2022, buying an estimated $305K and bringing the position to 13,211 shares worth $2.22M. The position accounts for 0.21% of the portfolio, ranked #159.

Seeyond first reported a position in CME in Q4 2018 and has held it in 17 quarters since. The position peaked at $13.7M in Q1 2019. 1,149 funds tracked by Wall St. Rank hold CME as of Q4 2022.

  • Seeyond held 13,211 shares of CME Group worth $2.22M as of Q4 2022.
  • Seeyond bought 1,756 CME Group shares in Q4 2022, an estimated $305K.
  • CME Group made up 0.21% of Seeyond's portfolio in Q4 2022, its #159 holding.
  • Seeyond first reported a position in CME Group in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's CME Group position peaked at $13.7M in Q1 2019.
  • 1,149 funds tracked by Wall St. Rank held CME Group as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.